Manufacturer

UCB

Pharmaceutical manufacturer based in Belgium

Belgium

Products listed: 42
Molecules: 11
Therapy areas: 4

UCB is a pharmaceutical manufacturer based in Belgium. MedsAcross lists 42 of its products across 11 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country: Belgium
Indian manufacturer: No
Also listed as: UCB, Inc.
US FDA labeler: YesSource: openFDA NDC directory

Source from this manufacturer

We supply UCB products through licensed channels, with the documents your regulator needs.

Filter all 42 products Request a quote

Neurology

29 presentations

Neurology overview

Medicine	Active ingredient	Register	Availability
Briviact 10 mg tabletOral	Brivaracetam	US FDA	Available on request
Briviact 10 mg/mL oral solutionOral	Brivaracetam	US FDA	Available on request
Briviact 100 mg tabletOral	Brivaracetam	US FDA	Available on request
Briviact 25 mg tabletOral	Brivaracetam	US FDA	Available on request
Briviact 50 mg tabletOral	Brivaracetam	US FDA	Available on request
Briviact 50 mg/5 mL injectable suspensionIntravenous	Brivaracetam	US FDA	Available on request
Briviact 75 mg tabletOral	Brivaracetam	US FDA	Available on request
Fintepla 2.2 mg/mL oral solutionOral	Fenfluramine	US FDA	Available on request
Keppra 100 mg/mL oral solutionOral	Levetiracetam	US FDA	Available on request
Keppra 1000 mg tabletOral	Levetiracetam	US FDA	Available on request
Keppra 250 mg tabletOral	Levetiracetam	US FDA	Available on request
Keppra 500 mg tabletOral	Levetiracetam	US FDA	Available on request
Keppra 500 mg/5 mL injectionIntravenous	Levetiracetam	US FDA	Available on request
Keppra 750 mg tabletOral	Levetiracetam	US FDA	Available on request
Keppra XR 500 mg extended-release tabletOral	Levetiracetam	US FDA	Available on request
Keppra XR 750 mg extended-release tabletOral	Levetiracetam	US FDA	Available on request
Neupro kit	Rotigotine	US FDA	Available on request
Neupro 1 mg/24 hours transdermal patchTransdermal	Rotigotine	US FDA	Available on request
Neupro 2 mg/24 hours transdermal patchTransdermal	Rotigotine	US FDA	Available on request
Neupro 3 mg/24 hours transdermal patchTransdermal	Rotigotine	US FDA	Available on request
Neupro 4 mg/24 hours transdermal patchTransdermal	Rotigotine	US FDA	Available on request
Neupro 6 mg/24 hours transdermal patchTransdermal	Rotigotine	US FDA	Available on request
Neupro 8 mg/24 hours transdermal patchTransdermal	Rotigotine	US FDA	Available on request
Vimpat 10 mg/mL oral solutionOral	Lacosamide	US FDA	Available on request
Vimpat 100 mg tabletOral	Lacosamide	US FDA	Available on request
Vimpat 150 mg tabletOral	Lacosamide	US FDA	Available on request
Vimpat 200 mg tabletOral	Lacosamide	US FDA	Available on request
Vimpat 200 mg/20 mL injectionIntravenous	Lacosamide	US FDA	Available on request
Vimpat 50 mg tabletOral	Lacosamide	US FDA	Available on request

Immunology and transplant

11 presentations

Immunology and transplant overview

Medicine	Active ingredient	Register	Availability
Bimzelx 160 mg/1 mL injectionSubcutaneous Cold chain	Bimekizumab	US FDA	Available on request
Bimzelx 320 mg/2 mL injectionSubcutaneous Cold chain	Bimekizumab	US FDA	Available on request
Cimzia kit Cold chain	Certolizumab pegol	US FDA	Available on request
Cimzia 200 mg/1 mL injectionSubcutaneous Cold chain	Certolizumab pegol	US FDA	Available on request
Rystiggo 280 mg/2 mL injectionSubcutaneous Cold chain	Rozanolixizumab	US FDA	Available on request
Rystiggo 420 mg/3 mL injectionSubcutaneous Cold chain	Rozanolixizumab	US FDA	Available on request
Rystiggo 560 mg/4 mL injectionSubcutaneous Cold chain	Rozanolixizumab	US FDA	Available on request
Rystiggo 840 mg/6 mL injectionSubcutaneous Cold chain	Rozanolixizumab	US FDA	Available on request
Zilbrysq 16.64 mg/0.416 mL injectionSubcutaneous	Zilucoplan	US FDA	Available on request
Zilbrysq 22.96 mg/0.574 mL injectionSubcutaneous	Zilucoplan	US FDA	Available on request
Zilbrysq 32.4 mg/0.81 mL injectionSubcutaneous	Zilucoplan	US FDA	Available on request

Rare diseases and enzyme replacement

1 presentation

Rare diseases and enzyme replacement overview

Medicine	Active ingredient	Register	Availability
Kygevvi 2 g/2 g powder for oral solutionOral	Doxecitine and Doxribtimine	US FDA	Available on request

Psychiatry

1 presentation

Psychiatry overview

Medicine	Active ingredient	Register	Availability
Nayzilam 5 mg/0.1 mL nasal sprayNasal	Midazolam	US FDA	Available on request

Molecules made

Bimekizumab Brivaracetam Certolizumab pegol Fenfluramine Levetiracetam Doxecitine and Doxribtimine Midazolam Rotigotine Rozanolixizumab Lacosamide Zilucoplan

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from UCB

Send a request for any of these products. We confirm the licensed source, documents and lead time.

Request a quote Manufacturers